The influence of diet on the gut microbiota and its consequences for health

Current Opinion in Biotechnology

Volumn 32, Issue , 2015, Pages 195-199

  Doré, Joël ^a   Blottière, Hervé ^a  

^a UMR1319 MICALIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIETARY FIBERS; GUT MICROBIOTA; HUMAN CELLS; INFLAMMATORY DISEASE; MICROBIOTAS; WELL BEING;

BIOTECHNOLOGY;

PREBIOTIC AGENT; PROBIOTIC AGENT;

BACTERIAL GROWTH; DIET; DIET THERAPY; DIETARY FIBER; HUMAN; INFECTION RISK; INTESTINE FLORA; LIFESTYLE; METAGENOMICS; MICROBIAL DIVERSITY; NONHUMAN; REVIEW; SPECIES RICHNESS; SYMBIOSIS; ANIMAL; FEEDING BEHAVIOR; INTESTINE; METAGENOME; MICROBIOLOGY; MICROFLORA;

ANIMALS; DIET; FEEDING BEHAVIOR; HUMANS; INTESTINES; LIFE STYLE; METAGENOME; MICROBIOTA;

EID: 84922593750     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2015.01.002     Document Type: Review

References (36)

1. Blottière H.M., de Vos W.M., Ehrlich S.D., Doré J. Human intestinal metagenomics-state of the art and future. Curr Opin Microbiol 2013, 16:232-239.
2. Lepage P., Leclerc M.C., Joossens M., Mondot S., Blottière H.M., Raes J., Ehrlich D., Doré J. A metagenomic insight into our gut's microbiome. Gut 2013, 62:146-158.
3. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., Nielsen T., Pons N., Levenez F., Yamada T., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
4. Li J., Jia H., Cai X., Zhong H., Feng Q., Sunagawa S., Arumugam M., Kultima J.R., Prifti E., Nielsen T., et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014, 32:834-841.
5. Nielsen H.B., Almeida M., Juncker A.S., Rasmussen S., Li J., Sunagawa S., Plichta D.R., Gautier L., Pedersen A.G., Le Chatelier E., et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat Biotechnol 2014, 32:822-828.
6. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., Fernandes G.R., Tap J., Bruls T., Batto J.M., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
7. Le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., Almeida M., Arumugam M., Batto J.M., Kennedy S., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013, 500:541-546.
8. Cotillard A., Kennedy S.P., Kong L.C., Prifti E., Pons N., Le Chatelier E., Almeida M., Quinquis B., Levenez F., Galleron N., et al. Dietary intervention impact on gut microbial gene richness. Nature 2013, 500:585-588.
9. Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G., Contreras M., Magris M., Hidalgo G., Baldassano R.N., Anokhin A.P., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
10. Dominguez-Bello M.G., Costello E.K., Contreras M., Magris M., Hidalgo G., Fierere N., Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010, 107:11971-11975.
11. Salminen S., Gibson G.R., McCartney A.L., Isolauri E. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 2004, 53:1388-1389.
12. Bager P., Simonsen J., Ethelberg S., Frisch M. Cesarean delivery and risk of intestinal bacterial infection. J Infect Dis 2010, 201:898-902.
13. Rook G.A. Hygiene hypothesis and autoimmune diseases. Clin Rev Allergy Immunol 2012, 42:5-15.
14. Missing Microbes-How the Overuse of Antibiotics is Fueling Our Modern Plagues 2014, M.J. Blaser. M.J. Blaser (Ed.).
15. De Filippo C., Cavalieri D., Di Paola M., Ramazzotti M., Poullet J.B., Massart S., Collini S., Pieraccini G., Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010, 107:14691-14696.
16. Wu G.D., Chen J., Hoffmann C., Bittinger K., Chen Y.Y., Keilbaugh S.A., Bewtra M., Knights D., Walters W.A., Knight R., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334:105-108.
17. Ou J., Carbonero F., Zoetendal E.G., DeLany J.P., Wang M., Newton K., Gaskins H.R., O'Keefe S.J. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr 2013, 98:111-120.
18. Schnorr S.L., Candela M., Rampelli S., Centanni M., Consolandi C., Basaglia G., Turroni S., Biagi E., Peano C., Severgnini M., et al. Gut microbiome of the Hadza hunter-gatherers. Nat Commun 2014, 5:3654. 10.1038/ncomms4654.
19. Kong L.C., Holmes B.A., Cotillard A., Habi-Rachedi F., Brazeilles R., Gougis S., Gausserès N., Cani P.D., Fellahi S., Bastard J.P., et al. Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PLoS ONE 2014, 9. 10.1371/journal.pone.0109434.
20. Flint H.J. The impact of nutrition on the human microbiome. Nutr Rev 2012, 70(Suppl 1):S10-S13.
21. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermúdez-Humarán L.G., Gratadoux J.-J., Blugeon S., Bridonneau C., Furet J.-P., Corthier G., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008, 105:16731-16736.
22. Rajilić-Stojanović M., Biagi E., Heilig H.G., Kajander K., Kekkonen R.A., Tims S., de Vos W.M. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011, 141:1792-1801.
23. Kong L.C., Tap J., Aron-Wisnewsky J., Pelloux V., Basdevant A., Bouillot J.L., Zucker J.D., Doré J., Clément K. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr 2013, 98:16-24.
24. Dewulf E.M., Cani P.D., Claus S.P., Fuentes S., Puylaert P.G., Neyrinck A.M., Bindels L.B., de Vos W.M., Gibson G.R., Thissen J.P., Delzenne N.M. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 2013, 62:1112-1121.
25. Chow J., Tang H., Mazmanian S.K. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr Opin Immunol 2011, 23:473-480.
26. Lepage P., Häsler R., Spehlmann M.E., Rehman A., Zvirbliene A., Begun A., Ott S., Kupcinskas L., Doré J., Raedler A., et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 2011, 141:227-236.
27. Ze X., Le Mougen F., Duncan S.H., Louis P., Flint H.J. Some are more equal than others: the role of keystone species in the degradation of recalcitrant substrates. Gut Microbe 2013, 4:236-240.
28. Claesson M.J., Cusack S., O'Sullivan O., Greene-Diniz R., de Weerd H., Flannery E., Marchesi J.R., Falush D., Dinan T., Fitzgerald G., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 2011, 108(Suppl 1):4586-4591.
29. Segain J.P., Raingeard de la Blétière D., Bourreille A., Leray V., Gervois N., Rosales C., Ferrier L., Bonnet C., Blottière H.M., Galmiche J.P. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 2000, 47:397-403.
30. Salonen A., Lahti L., Salojärvi J., Holtrop G., Korpela K., Duncan S.H., Date P., Farquharson F., Johnstone A.M., Lobley G.E., et al. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J 2014, 8:2218-2230.
31. Korpela K., Flint H.J., Johnstone A.M., Lappi J., Poutanen K., Dewulf E., Delzenne N., de Vos W.M., Salonen A. Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLoS ONE 2014, 9. 10.1371/journal.pone.0090702.
32. Everard A., Cani P.D. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol 2013, 27:73-83.
33. Kuitunen M. Probiotics prevent allergic diseases in high-risk children. Expert Rev Clin Immunol 2009, 5:221-224.
34. van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E.G., de Vos W.M., Visser C.E., Kuijper E.J., Bartelsman J.F., Tijssen J.G., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013, 368:407-415.
35. Fuentes S., van Nood E., Tims S., Heikamp-de Jong I., ter Braak C.J.F., Keller J.J., Zoetendal E., de Vos W.M. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. ISME J 2014, 8:1621-1633.
36. Kootte R.S., Vrieze A., Holleman F., Dallinga-Thie G.M., Zoetendal E.G., de Vos W.M., Groen A.K., Hoekstra J.B., Stroes E.S., Nieuwdorp M. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab 2012, 14:112-120.